Meet The Team

  • Jill Walker PhD

    FOUNDER

    With over two decades of experience in the pharmaceutical and healthcare industries, specialising in Precision Medicines, Jill brings deep expertise in biomarker discovery, clinical development, regulatory strategy, and commercialisation.

    Jill is recognised as a strategic and visionary leader with a track record of managing complex projects, ensuring goals are not only met but exceeded.

  • Emma Brown PhD

    PARTNER

    In a career spanning drug and diagnostic development and academic research, Emma has held leadership roles driving companion diagnostic development and delivery of precision medicine strategies for complex Phase III clinical trials, specialising in IVDR.

    With a pioneering mindset, she excels at tackling challenges, setting precedents, and developing innovative processes to optimise outcomes and efficiency.

  • The BEACON Network

    At Beacon, we bring together a team of over 20 highly skilled associates with expertise spanning every stage of precision medicine development:

    Technology Experts – Specialists in next-generation technologies.

    Commercial Leaders – Experienced in market strategy, pricing, reimbursement, and launch planning.

    Diagnostic Validation Experts – Professionals in assay development, analytical validation, and regulatory compliance.

    Drug Development Strategists – Leaders in clinical trial design, regulatory submissions, and lifecycle management.

Learn more

  • A world where every patient receives the right treatment at the right time.

  • To empower innovators to deliver life-changing treatments, by sharing our substantial experience of bringing Precision Medicines to patients.

  • Drug Development experts with substantial experience spanning:

    Deep Expertise: Specialists in biomarkers, diagnostics, and regulatory pathways.

    Proven Results: Track record of delivering over 6 Precision Medicines to the market.

    Integrated Approach: Seamless alignment of clinical, regulatory, and commercial strategies.

    Client-Centric Focus: Customised solutions designed to deliver measurable ROI and patient impact.

    Innovation: New patient segments, identification of aggressive disease, first in class diagnostics.

    Delivered Industry Firsts: Novel ctDNA diagnostics, new patient populations, Dx harmonisation.